Please login to the form below

Not currently logged in

HBV vaccine prevents liver cancer

Research demonstrates protection offered by vaccination programme

A paper published in Journal of the National Cancer Institute has indicated that babies vaccinated against hepatitis B have significantly reduced incidence of liver cancer in later life.

Researchers in Taiwan followed up babies vaccinated as part of a universal hepatitis B virus vaccination programme launched in July 1984. Of 1,958 patients, aged 6–29 years, diagnosed with cancer of the liver (hepatocellular carcinoma) they found only 64 cases in the vaccinated group compared with 444 in the unvaccinated birth cohorts.

Hepatitis B virus (HBV) is a major cause of liver cancer and children generally contract it from their mothers. The virus can also be transmitted by sex, intravenous drug use or blood transfusion.

22nd September 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...